{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T12:29:40Z","timestamp":1781008180398,"version":"3.54.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Strongyloidiasis is a gastrointestinal parasitic infection caused by percutaneous infection with <jats:italic>Strongyloides stercoralis<\/jats:italic>. Digestive symptoms such as diarrhea and abdominal pain are the main manifestation, but serious infections such as septicemia, purulent meningitis, and bacterial pneumonia may occur in individuals harboring human T-lymphotropic virus type 1 (HTLV-1) or who are immunocompromised. Although coinfection with <jats:italic>Strongyloides stercoralis<\/jats:italic> and HTLV-1 can lead to chronic strongyloidiasis and a disseminated form of the disease, there is a high rate of response to the anthelmintic ivermectin.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>We report a case of strongyloidiasis infection syndrome that was difficult to differentiate from immune reconstitution inflammatory syndrome (IRIS) for various reasons. The patient had been treated with the corticosteroids tacrolimus (Tac) and mycophenolate mofetil (MMF) for systemic lupus erythematosus (SLE) with lupus nephritis and pancytopenia. When the steroid was reduced, she developed cytomegalovirus (CMV) enteritis, and her respiratory status rapidly deteriorated immediately after the withdrawal of Tac and MMF. It was difficult to distinguish immune reconstitution inflammatory syndrome from strongyloidiasis infection syndrome because stool cultures were negative and eosinophils were not increased. Bronchoscopy revealed viable <jats:italic>Strongyloides<\/jats:italic>, leading to a diagnosis of strongyloidiasis infection syndrome, but the patient died despite treatment.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Both corticosteroid therapy and HTLV-1 infection can be associated with a decrease of eosinophils, despite the presence of parasitic infection. In conclusion, even if multiple culture tests are negative, the risk of parasitic infection should be assessed in patients receiving immunosuppressants and steroids even in non-endemic areas.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12879-020-05195-0","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T09:25:31Z","timestamp":1593681931000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Fatal outcome in a patient under immunosuppressant therapy infected with human T-lymphotropic virus type 1 (HTLV-1), cytomegalovirus (CMV) and Strongyloides stercoralis: a case report"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3137-0138","authenticated-orcid":false,"given":"Chisato","family":"Ashida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Nozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Funauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,2]]},"reference":[{"issue":"3","key":"5195_CR1","doi-asserted-by":"publisher","first-page":"645","DOI":"10.4269\/ajtmh.16-0923","volume":"97","author":"A Requena-M\u00e9ndez","year":"2017","unstructured":"Requena-M\u00e9ndez A, Buonfrate D, Gomez-Junyent J, Zammarchi L, Bisoffi Z, Mu\u00f1oz J. Evidence-based guidelines for screening and Management of Strongyloidiasis in non-endemic countries. Am J Trop Med Hyg. 2017;97(3):645\u201352.","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"5195_CR2","first-page":"485","volume":"32","author":"E Eusebio-Ponce","year":"2019","unstructured":"Eusebio-Ponce E, Anguita E, Paulino-Ramirez R, Candel FJ. HTLV-1 infection: an emerging risk. Pathogenesis, epidemiology, diagnosis and associated diseases. Rev Esp Quimioter. 2019;32(6):485\u201396.","journal-title":"Rev Esp Quimioter"},{"key":"5195_CR3","doi-asserted-by":"publisher","unstructured":"Vadlamudi RS, Chi DS, Krishnaswamy G. Intestinal strongyloidiasis and hyperinfection syndrome. Clin Mol Allergy. 2006;4:8. Published 2006 May 30. doi:https:\/\/doi.org\/10.1186\/1476-7961-4-8.","DOI":"10.1186\/1476-7961-4-8"},{"issue":"1","key":"5195_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.idc.2018.10.006","volume":"33","author":"A Krolewiecki","year":"2019","unstructured":"Krolewiecki A, Nutman T. Strongyloidiasis. Infect Dis Clin N Am. 2019;33(1):135\u201351.","journal-title":"Infect Dis Clin N Am"},{"key":"5195_CR5","doi-asserted-by":"crossref","unstructured":"Mukaigawar M, Narita M, Shiiki S, Takayama Y, Takakura S, Kishaba T. Clinical Characteristics of Disseminated Strongyloidiasis, Japan, 1975\u20132017. Emerg Infect Dis. 2020;3(26).","DOI":"10.3201\/eid2603.190571"},{"key":"5195_CR6","doi-asserted-by":"crossref","unstructured":"Vadlamudi RS, Chi DD, Krishnaswamy G. Intestinal strongyloidiasis and hyperinfection syndrome. Clin Mol Allergy. 2006;4(8).","DOI":"10.1186\/1476-7961-4-8"},{"key":"5195_CR7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.2332\/allergolint.10-RAI-0260","volume":"59","author":"T Shiohara","year":"2010","unstructured":"Shiohara T, Kurata M, Mizukawa Y, Kano Y. Recognition of immune reconstitution syndrome necessary for better Management of Patients with severe drug eruptions and those under immunosuppressive therapy. Allergol Int. 2010;59:333\u201343.","journal-title":"Allergol Int"},{"issue":"1","key":"5195_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1177\/2325957416673149","volume":"16","author":"H Bar-Yoseph","year":"2017","unstructured":"Bar-Yoseph H, Zohar Y, Lorber M. Strongyloidiasis-Related IRIS. J Int Assoc Provid AIDS Care. 2017;16(1):8\u201310.","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"5195_CR9","doi-asserted-by":"crossref","unstructured":"Walker NF, Scriven J, Meintjes G, Wilkinson RJ. Immune reconstitution inflammatory syndrome in HIV-infected patients. HIV AIDS (Auckl). 2015;7:49\u201364. Published 2015 Feb 12.","DOI":"10.2147\/HIV.S42328"},{"issue":"6","key":"5195_CR10","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1111\/tbed.13310","volume":"66","author":"E Ahmadpour","year":"2019","unstructured":"Ahmadpour E, Ghanizadegan MA, Razavi A, et al. Strongyloides stercoralis infection in human immunodeficiency virus-infected patients and related risk factors: a systematic review and meta-analysis. Transbound Emerg Dis. 2019;66(6):2233\u201343.","journal-title":"Transbound Emerg Dis"},{"key":"5195_CR11","doi-asserted-by":"crossref","unstructured":"Choo HMC, Cher WQ, Kwan YH, Fong WWS. Risk factors for cytomegalovirus disease in systemic lupus erythematosus (SLE): a systematic review. Adv Rheumatol. 2019;59(1):12. Published 2019 Mar 18.","DOI":"10.1186\/s42358-019-0055-y"},{"issue":"1","key":"5195_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1590\/2175-8239-jbn-3838","volume":"40","author":"K Lino","year":"2018","unstructured":"Lino K, Trizzotti N, Carvalho FR, et al. Pp65 antigenemia and cytomegalovirus diagnosis in patients with lupus nephritis: report of a series. J Bras Nefrol. 2018;40(1):44\u201352.","journal-title":"J Bras Nefrol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05195-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-05195-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05195-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T23:21:03Z","timestamp":1625181663000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05195-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,2]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5195"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05195-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,2]]},"assertion":[{"value":"17 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent for publication was obtained from the patient for publication of this case report and any individual person\u2019s data in any form (including individual details, images or videos). However, because the patient died before the decision was made to submit this manuscript to the BMC Journal, the written consent from the patient was on our hospital\u2019s own form rather than the BMC consent form. Using the BMC consent form, we renewed written consent from the patient\u2019s daughter for publication of this case report and any individual person\u2019s data in the BMC Journal. This paper has been anonymized for the patient\u2019s protection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"470"}}